Charles Schwab’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.09M Buy
1,336,030
+170,635
+15% +$906K ﹤0.01% 2171
2025
Q1
$10.3M Buy
1,165,395
+39,860
+4% +$354K ﹤0.01% 1935
2024
Q4
$15.4M Buy
1,125,535
+42,233
+4% +$579K ﹤0.01% 1827
2024
Q3
$29.7M Buy
1,083,302
+41,374
+4% +$1.13M 0.01% 1464
2024
Q2
$25.5M Buy
1,041,928
+55,462
+6% +$1.36M ﹤0.01% 1513
2024
Q1
$21M Buy
986,466
+60,307
+7% +$1.29M ﹤0.01% 1576
2023
Q4
$17.7M Buy
926,159
+41,353
+5% +$791K ﹤0.01% 1667
2023
Q3
$14.2M Buy
884,806
+24,665
+3% +$396K ﹤0.01% 1714
2023
Q2
$19.9M Sell
860,141
-10,577
-1% -$245K 0.01% 1503
2023
Q1
$20.2M Buy
870,718
+30,084
+4% +$699K 0.01% 1462
2022
Q4
$12.2M Buy
840,634
+4,585
+0.5% +$66.5K ﹤0.01% 1741
2022
Q3
$16M Buy
836,049
+21,381
+3% +$408K 0.01% 1539
2022
Q2
$14.8M Buy
814,668
+4,547
+0.6% +$82.6K 0.01% 1607
2022
Q1
$20.4M Buy
810,121
+17,390
+2% +$438K 0.01% 1532
2021
Q4
$21.9M Sell
792,731
-7,163
-0.9% -$198K 0.01% 1509
2021
Q3
$25.8M Sell
799,894
-35,666
-4% -$1.15M 0.01% 1359
2021
Q2
$25.6M Buy
835,560
+15,082
+2% +$461K 0.01% 1389
2021
Q1
$25M Sell
820,478
-16,393
-2% -$499K 0.01% 1351
2020
Q4
$16.6M Buy
836,871
+34,037
+4% +$673K 0.01% 1535
2020
Q3
$10.5M Buy
802,834
+3,829
+0.5% +$49.9K ﹤0.01% 1659
2020
Q2
$9.06M Sell
799,005
-28,248
-3% -$320K ﹤0.01% 1711
2020
Q1
$11.8M Buy
827,253
+81,910
+11% +$1.17M 0.01% 1350
2019
Q4
$20.3M Buy
745,343
+3,641
+0.5% +$99.1K 0.01% 1203
2019
Q3
$21.2M Sell
741,702
-40,446
-5% -$1.16M 0.01% 1105
2019
Q2
$21.7M Buy
782,148
+5,141
+0.7% +$143K 0.01% 1078
2019
Q1
$25.8M Sell
777,007
-18,997
-2% -$631K 0.02% 951
2018
Q4
$23.1M Buy
796,004
+11,893
+2% +$346K 0.02% 902
2018
Q3
$36.1M Buy
784,111
+16,603
+2% +$764K 0.02% 715
2018
Q2
$28.7M Buy
767,508
+108,303
+16% +$4.05M 0.02% 821
2018
Q1
$19.5M Sell
659,205
-1,524
-0.2% -$45K 0.02% 1021
2017
Q4
$22.7M Buy
660,729
+29,797
+5% +$1.02M 0.02% 901
2017
Q3
$22.8M Sell
630,932
-58,435
-8% -$2.11M 0.02% 828
2017
Q2
$17.8M Sell
689,367
-9,083
-1% -$235K 0.02% 951
2017
Q1
$13.4M Buy
698,450
+29,348
+4% +$564K 0.01% 1099
2016
Q4
$11.2M Buy
669,102
+102,593
+18% +$1.71M 0.01% 1169
2016
Q3
$11.7M Buy
566,509
+19,931
+4% +$410K 0.01% 1047
2016
Q2
$16.7M Buy
546,578
+60,723
+12% +$1.86M 0.02% 743
2016
Q1
$18.2M Buy
485,855
+37,663
+8% +$1.41M 0.02% 660
2015
Q4
$19.3M Buy
448,192
+147,593
+49% +$6.37M 0.03% 613
2015
Q3
$11.3M Buy
300,599
+42,247
+16% +$1.58M 0.02% 916
2015
Q2
$8.78M Buy
258,352
+117,644
+84% +$4M 0.01% 1146
2015
Q1
$4.98M Sell
140,708
-32,659
-19% -$1.16M 0.01% 1511
2014
Q4
$5.91M Sell
173,367
-39,405
-19% -$1.34M 0.01% 1318
2014
Q3
$8.21M Buy
212,772
+4,379
+2% +$169K 0.01% 974
2014
Q2
$8.11M Buy
208,393
+19,952
+11% +$777K 0.01% 999
2014
Q1
$6.44M Buy
188,441
+39,807
+27% +$1.36M 0.01% 1126
2013
Q4
$3.12M Buy
148,634
+35,149
+31% +$738K 0.01% 1626
2013
Q3
$2.87M Buy
113,485
+11,693
+11% +$296K 0.01% 1610
2013
Q2
$2.78M Buy
+101,792
New +$2.78M 0.01% 1528